NCT06727656

Brief Summary

Determine the combined effect of training in hypoxia and nitrate supplementation on the performance and health of athletes at sea-level and altitude conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 22, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2020

Completed
4 years until next milestone

First Submitted

Initial submission to the registry

July 24, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

December 11, 2024

Completed
Last Updated

December 11, 2024

Status Verified

December 1, 2024

Enrollment Period

1.5 years

First QC Date

July 24, 2024

Last Update Submit

December 4, 2024

Conditions

Outcome Measures

Primary Outcomes (11)

  • Performance adaptations

    Time-to-task failure (time sustained)

    Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

  • Performance adaptations

    Time trials (time performed)

    Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

  • Performance adaptations

    VO2 kinetics (time constant and amplitude of fast and slow oxygen components)

    Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

  • Cardiovascular and neuromuscular adaptations

    Maximal oxygen uptake (VO2max: absolute and relative value)

    Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

  • Cardiovascular and neuromuscular adaptations

    Lactate threshold (absolute and percentage of VO2max)

    Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

  • Cardiovascular and neuromuscular adaptations

    Muscular oxygen saturation (SmO2)

    Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

  • Skeletal muscle adaptations

    Oxidative enzyme activity (cytochrome oxidase subunit IV), citrate synthase, transcription factors (HIF-1alpha and PGC-1alpha) and GLUT4 - assessed through standard enzymatic fluorometric assay and western bllotting

    Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

  • Skeletal muscle adaptations

    Mitochondrial and capillary density, capillary-to-fibre ratio and fibre cross-section area - cryosections cut with a cryostat and further samples analysed by fluorescence microscopy

    Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

  • Haematological adaptations

    Blood pressure (Hmmg), mean arterial pressure (calculated as 1/3 \* systolic pressure + 2/3 \* diastolic pressure)

    Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

  • Haematological adaptations

    Plasma \[NO2-\] and \[NO3-\], erythropoietin (EPO), haemoglobin (Hb) and haematocrit (Hct) - all assays on plasma sample analysed by spectrophometry

    Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

  • Oxidative stress and antioxidant markers adaptations

    Nitrotyrosine, malondialdehyde, ferric-reducing antioxidant power and superoxide dismutase concentrations - all assays on plasma sample analysed by spectrophometry

    Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

Secondary Outcomes (5)

  • Sleep and cardiac autonomic activity adaptations

    Moment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)

  • Sleep and cardiac autonomic activity adaptations

    Moment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)

  • Sleep and cardiac autonomic activity adaptations

    Moment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)

  • Sleep and cardiac autonomic activity adaptations

    Moment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)

  • Sleep and cardiac autonomic activity adaptations

    Moment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)

Study Arms (3)

HNO: High intensity interval training (HIIT) + nitrate supllementation (NO3-).

EXPERIMENTAL

Performed 12 high-intensity interval-training (HIIT) sessions during a 4-week period (3 sessions/ week) under normobaric hypoxia conditions (FiO2=\~13%, \~3000 m) with NO3- supplement.

Combination Product: Nitrate + Hypoxia

HPL: High intensity interval training (HIIT) + placebo supllementation.

ACTIVE COMPARATOR

Performed 12 high-intensity interval-training (HIIT) sessions during a 4-week period (3 sessions/ week) under normobaric hypoxia conditions (FiO2=\~13%, \~3000 m) with placebo supplement.

Dietary Supplement: Placebo + Hypoxia

CON: High intensity interval training (HIIT) + placebo supllementation.

PLACEBO COMPARATOR

Performed 12 high-intensity interval-training (HIIT) sessions during a 4-week period (3 sessions/ week) under normoxic conditions (FiO2=\~20.9%) with placebo supplement.

Other: Control

Interventions

Nitrate + HypoxiaCOMBINATION_PRODUCT

The combined effect of nitrate supplementation and hypoxia training on both performance and health at sea-level and altitude conditions.

Also known as: Beetroot Juice + Atitude training
HNO: High intensity interval training (HIIT) + nitrate supllementation (NO3-).
Placebo + HypoxiaDIETARY_SUPPLEMENT

The combined effect of placebo supplementation and hypoxia training on both performance and health at sea-level and altitude conditions.

Also known as: Placebo Juice + Atitude training
HPL: High intensity interval training (HIIT) + placebo supllementation.
ControlOTHER

The combined effect of placebo supplementation and normoxia training on both performance and health at sea-level and altitude conditions.

Also known as: Placebo Juice + Normoxia training
CON: High intensity interval training (HIIT) + placebo supllementation.

Eligibility Criteria

Age18 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • trained male subjects, regularly involved in competitive running, cycling and/ or triathlon events (4-5 times per week) in the past five years

You may not qualify if:

  • smoking or other chronic issues
  • using medication or dietary supplements in the last 3 months, or during the duration of the study
  • being exposed to altitude (≥2000 m) in the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Trás-os-Montes e Alto-Douro

Vila Real, Portugal

Location

MeSH Terms

Conditions

Hypoxia

Interventions

Nitrates

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnionsIonsElectrolytesInorganic ChemicalsNitric AcidNitrogen CompoundsOrganic Chemicals

Study Officials

  • Ana Sousa, PhD

    University of Maia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

July 24, 2024

First Posted

December 11, 2024

Study Start

February 1, 2019

Primary Completion

July 22, 2020

Study Completion

July 22, 2020

Last Updated

December 11, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Study overview, participation criteria, study plan, contacts

Locations